Literature DB >> 3741860

Kinetics of interfacial catalysis by phospholipase A2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles.

M K Jain, J Rogers, D V Jahagirdar, J F Marecek, F Ramirez.   

Abstract

In this and the following three papers we examine the kinetics of action of pig pancreatic phospholipase A2 on vesicles of anionic phospholipids without any additives. The results provide the first unequivocal demonstration of interfacial catalysis in intravesicle scooting mode. In this paper we describe the conditions in which the action of pig pancreatic phospholipase A2 on DMPMe (ester) vesicles in the absence of any additive commences without a latency. Under these conditions the free monomer substrate concentration is insignificant; the bilayer enclosed vesicle organization remains intact even when all the substrate in the outer monolayer has been hydrolyzed; the rate of intervesicle exchange and the rate of transbilayer movement (flip-flop) of molecules is negligibly slow; and the rate of fusion of vesicles is insignificant. Thus an enzyme molecule bound to one vesicle hydrolyzes all the DMPMe molecules in the outer monolayer of the vesicle by a first-order process with a rate constant of 0.6 per min at 30 degrees C; or viewed another way, one enzyme molecule in a DMPMe vesicle can hydrolyze all the available substrate molecules at the rate of 3000 per min. At low anion concentrations excess substrate vesicles are not hydrolyzed unless the rate of intervesicle exchange of the bound enzyme is stimulated by anions in the aqueous phase. Higher calcium concentrations promote not only homofusion of DMPMe vesicles but also heterofusion of DMPMe and DMPC vesicles. It is proposed that calcium-induced isothermal lateral phase separation in DMPMe vesicles induces defects in the bilayer organization, and such defects are the sites for phospholipase A2 binding and for heterofusion with DMPC (ester) vesicles which do not have such sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741860     DOI: 10.1016/0005-2736(86)90541-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Crystal structure of the yeast Sac1: implications for its phosphoinositide phosphatase function.

Authors:  Andrew Manford; Tian Xia; Ajay Kumar Saxena; Christopher Stefan; Fenghua Hu; Scott D Emr; Yuxin Mao
Journal:  EMBO J       Date:  2010-04-13       Impact factor: 11.598

2.  Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation.

Authors:  S A Tatulian
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

3.  Competitive inhibition of phospholipase A2 in vesicles.

Authors:  M K Jain; W Yuan; M H Gelb
Journal:  Biochemistry       Date:  1989-05-16       Impact factor: 3.162

4.  Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.

Authors:  Rob C Oslund; Michael H Gelb
Journal:  Biochemistry       Date:  2012-10-18       Impact factor: 3.162

5.  Bidirectional control of sphingomyelinase activity and surface topography in lipid monolayers.

Authors:  María Laura Fanani; Steffen Härtel; Rafael G Oliveira; Bruno Maggio
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

6.  Substrate specificity of O-alkylglycerol monooxygenase (E.C. 1.14.16.5), solubilized from rat liver microsomes.

Authors:  J Kötting; C Unger; H Eibl
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

7.  Assay of phospholipases A(2) and their inhibitors by kinetic analysis in the scooting mode.

Authors:  M K Jain; B Z Yu; M H Gelb; O G Berg
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

8.  Lactadherin inhibits secretory phospholipase A2 activity on pre-apoptotic leukemia cells.

Authors:  Steffen Nyegaard; Valerie A Novakovic; Jan T Rasmussen; Gary E Gilbert
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.